Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

about

A critical review on ramucirumab in the treatment of advanced urothelial cancer.

P2860

Q47787312-F6653ED9-1177-4E00-B672-508B14E2A885

P2860

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Item

http://www.wikidata.org/entity/Q45053173

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@en

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@nl

type

Item

label

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@en

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@nl

prefLabel

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@en

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@nl

P1476

Randomized Phase II Study of R ...... d or Metastatic Breast Cancer.

@en

P2093

Agustin A Garcia

http://www.w3.org/2001/XMLSchema#string

Anil Joy

http://www.w3.org/2001/XMLSchema#string

Denise A Yardley

http://www.w3.org/2001/XMLSchema#string

Gladys Rodriguez

http://www.w3.org/2001/XMLSchema#string

James Khatcheressian

http://www.w3.org/2001/XMLSchema#string

John Kauh

http://www.w3.org/2001/XMLSchema#string

Kathy Miller

http://www.w3.org/2001/XMLSchema#string

Linda T Vahdat

http://www.w3.org/2001/XMLSchema#string

Ling Gao

http://www.w3.org/2001/XMLSchema#string

Mohamad A Salkeni

http://www.w3.org/2001/XMLSchema#string

P2860

Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis

Microenvironmental regulation of metastasis

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

What is the evidence that tumors are angiogenesis dependent?

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents.

Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.

Safety and Pharmacokinetics of Second-line Ramucirumab plus FOLFIRI in Japanese Patients with Metastatic Colorectal Carcinoma.

Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.

P304

245-254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2016-0265

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joseph A Sparano

P577

2017-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28220020

http://www.w3.org/2001/XMLSchema#string

P932

5344637

http://www.w3.org/2001/XMLSchema#string

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

about

P2860

P2860

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932